Phenyl carbamates
AssigneeProterra Inc.
InventorsMarta W. Rosin, Michael Chorev, Zeev Tashma
Life of this patent
Estimating the term…
Abstract
Phenyl carbamates of the general formula ##STR1## wherein R.sub.1 to R.sub.5 are as defined in the claims, are useful as pharmaceuticals.
Claims4
N-cyclohexyl-3-[1-(dimethylamino)ethyl]phenyl carbamate and pharmacologically acceptable salts thereof.
N-allyl-3-[1-(dimethylamino)ethyl]phenyl carbamate and pharmacologically acceptable salts thereof.
N-ethyl, N-methyl-3-[1-(dimethylamino)ethyl]phenyl carbamate and pharmacologically acceptable salts thereof.
A method of treating a subject suffering from senile dementia, Alzhemier's disease, Huntingdon's chorea, tardive dyskinesias,, hyperkinesia, mania, acute confusion disorders, Friedrich's ataxia and Down's syndrome, which comprises administering to such a subject a therapeutically effective amount of a compound selected from the group consisting of N-cyclohexyl-3-[1-(dimethylamino)ethyl]phenyl carbamate, N-allyl-3-[1-(dimethylamino)ethyl]phenyl carbamate, N-ethyl, N-methyl-3[1-(dimethylamino)ethyl]phenyl carbamate, and pharmacologically acceptable salts thereof.
Dependencies are inferred from the claim text.